Cybin Inc. Common Stock
HELP
Rank in Stocks
#11772
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Share Price
$6.89
Last synced: 2026-11-18
Market Cap
$503.43M
Change (1 day)
-4.31%
Change (1 year)
-
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cybin Inc. Common Stock (HELP)
Category
Healthcare
P/B ratio for Cybin Inc. Common Stock (HELP)
P/B ratio as of November 2026 TTM: 2.30
According to Cybin Inc. Common Stock's latest financial reports and stock price, its current price-to-book ratio (TTM) is 2.30. At the end of 2025 the company had a P/B ratio of 7.14.
P/B ratio history for Cybin Inc. Common Stock from 2017 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 2.30 | -67.81% |
| 2025 | 7.14 | 1,050.06% |
| 2024 | 0.62 | -99.21% |
| 2023 | 78.89 | 4.77% |
| 2022 | 75.29 | -97.88% |
| 2021 | 3.54K | 254.65% |
| 2020 | 999.07 | -20.49% |
| 2019 | 1.26K | -67.26% |
| 2018 | 3.84K | 126.59% |
| 2017 | 1.69K | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 6.5305 | 184.14% |
US
|
|
| 13.101 | 470.03% |
US
|
|
| 4.451 | 93.66% |
AU
|
|
| 4.8339 | 110.33% |
BE
|
|
| 7.2161 | 213.98% |
NL
|
Questions about Cybin Inc. Common Stock's P/B ratio
What is Cybin Inc. Common Stock's P/B ratio?
Cybin Inc. Common Stock's P/B ratio is 2.30, as of Nov 2026.
What was Cybin Inc. Common Stock's P/B ratio in 2025?
In 2025, Cybin Inc. Common Stock's P/B ratio was 7.14, compared with 0.62 in 2024.
How has Cybin Inc. Common Stock's P/B ratio changed since 2020?
From 2020 to 2025, Cybin Inc. Common Stock's P/B ratio was highest in 2021 (3.54K) and lowest in 2024 (0.62).
How does Cybin Inc. Common Stock's P/B ratio compare with similar companies?
Cybin Inc. Common Stock's P/B ratio (2.30) is lower than that of all 5 similar companies listed above. The highest among them is Moderna, Inc., with 13.10.